Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded by StockNews.com to Strong-Buy Rating
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday. Aurinia Pharmaceuticals Price Performance Shares of AUPH stock opened at $8.29 on Thursday. The business’s fifty day moving average is $8.09 […]
More Stories
The T-Cell Suppression Scandal: How Bureaucratic Red Tape Delayed a Life-Saving Medical Breakthrough
By Stephen Zogopoulos, USNN World News For decades, the medical community has sought a more effective, long-lasting approach to fighting...
Credit Cards, Savings Accounts, Money Market: Best of the Best
By Rodd Mann Consumers are using credit cards like never before, with credit card balances currently at an all-time high....
CDC Says Measles Cases Confirmed in 19 States This Year
By Jack Phillips Measles cases have risen across the United States, with cases reported in 19 states in 2025, according...
4th Missing US Soldier Found Dead in Lithuania
By Rachel Acenas The body of a fourth U.S. Army soldier who went missing during a training exercise in Lithuania...
Senate Judiciary Chair Introduces Bill to End Nationwide Injunctions
By Sam Dorman Senate Judiciary Chair Chuck Grassley (R-Iowa) introduced legislation on March 31 to prevent courts from issuing nationwide...
Maine Gets Final Warning on Males in Female Sports
By Naveen Athrappully The U.S. Department of Education issued a final warning to the state of Maine, telling it to...